Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Schenone

Showing results (101-110 of 173) with videos related to

Pageof 18
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actionsAngelo Ranise, Andrea Spallarossa, Olga Bruno, et al.
International Journal of Pharmaceutics|July 27, 2025
Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatmentFederica Poggialini, Enrico Rango, Chiara Vagaggini, et al.
Bioorganic Chemistry|November 19, 2025
Synthesis, carbonic anhydrase inhibition and in silico insights of 4-formyl-2-nitrophenyl naphthalene-2-sulfonate hybrid thiosemicarbazonesKhawar Abbas, Muhammad Islam, Muhammad Tayyab, et al.
Cell Cycle (Georgetown, Tex.)|February 16, 2012
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibitionMartina Cozzi, Francesca Giorgi, Eleonora Marcelli, et al.
Organic & Biomolecular Chemistry|March 11, 2011
Substituted pyrazolo[3,4-b]pyridines as human A1 adenosine antagonists: developments in understanding the receptor stereoselectivityTiziano Tuccinardi, Alessandra Tania Zizzari, Chiara Brullo, et al.
European Journal of Medicinal Chemistry|February 28, 2004
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1H-pyrazolo[3,4-d]pyrimidines 4-amino substituted and their biological evaluationSilvia Schenone, Olga Bruno, Francesco Bondavalli, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl InhibitorsGiulia Vignaroli, Claudio Zamperini, Elena Dreassi, et al.
Scientific Reports|February 23, 2016
Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug deliveryGiulia Vignaroli, Pierpaolo Calandro, Claudio Zamperini, et al.
European Journal of Medicinal Chemistry|October 27, 2004
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell lineSilvia Schenone, Olga Bruno, Francesco Bondavalli, et al.
Bioorganic & Medicinal Chemistry|July 11, 2025
Synthesis of 6-ethoxyphenyl 4-fluorobenzenesulfonate-tagged thiosemicarbazones as carbonic anhydrase inhibitors: In-vitro and in silico approachIqra Munir, Hina Aftab, Abdul Asim Farooq, et al.
Pageof 18

Showing results (101-110 of 173) with videos related to

Sort By:
Pageof 18
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actionsAngelo Ranise, Andrea Spallarossa, Olga Bruno, et al.
International Journal of Pharmaceutics|July 27, 2025
Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatmentFederica Poggialini, Enrico Rango, Chiara Vagaggini, et al.
Bioorganic Chemistry|November 19, 2025
Synthesis, carbonic anhydrase inhibition and in silico insights of 4-formyl-2-nitrophenyl naphthalene-2-sulfonate hybrid thiosemicarbazonesKhawar Abbas, Muhammad Islam, Muhammad Tayyab, et al.
Cell Cycle (Georgetown, Tex.)|February 16, 2012
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibitionMartina Cozzi, Francesca Giorgi, Eleonora Marcelli, et al.
Organic & Biomolecular Chemistry|March 11, 2011
Substituted pyrazolo[3,4-b]pyridines as human A1 adenosine antagonists: developments in understanding the receptor stereoselectivityTiziano Tuccinardi, Alessandra Tania Zizzari, Chiara Brullo, et al.
European Journal of Medicinal Chemistry|February 28, 2004
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1H-pyrazolo[3,4-d]pyrimidines 4-amino substituted and their biological evaluationSilvia Schenone, Olga Bruno, Francesco Bondavalli, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl InhibitorsGiulia Vignaroli, Claudio Zamperini, Elena Dreassi, et al.
Scientific Reports|February 23, 2016
Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug deliveryGiulia Vignaroli, Pierpaolo Calandro, Claudio Zamperini, et al.
European Journal of Medicinal Chemistry|October 27, 2004
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell lineSilvia Schenone, Olga Bruno, Francesco Bondavalli, et al.
Bioorganic & Medicinal Chemistry|July 11, 2025
Synthesis of 6-ethoxyphenyl 4-fluorobenzenesulfonate-tagged thiosemicarbazones as carbonic anhydrase inhibitors: In-vitro and in silico approachIqra Munir, Hina Aftab, Abdul Asim Farooq, et al.
Pageof 18